Episode 87 of TGen Talks features Dr. Haiyong Han, who dives into his latest work on one of the deadliest of cancers: pancreatic cancer.
He breaks down why this disease is so hard to catch early, how it can grow silently for years before symptoms appear, and why identifying true positives in general population is such a big challenge.
Dr. Han also shares promising progress toward a new non-invasive screening test that could one day enable earlier detection of pancreatic cancer. The goal? To turn this deadly disease into a more manageable condition, and give patients real hope for the future.
As we recognize Pancreatic Cancer Awareness Month in November, this episode emphasizes the urgent need for improved diagnostic methods, more effective treatments, and continued research to change the outcome for patients everywhere.
All content for TGen Talks is the property of TGen and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Episode 87 of TGen Talks features Dr. Haiyong Han, who dives into his latest work on one of the deadliest of cancers: pancreatic cancer.
He breaks down why this disease is so hard to catch early, how it can grow silently for years before symptoms appear, and why identifying true positives in general population is such a big challenge.
Dr. Han also shares promising progress toward a new non-invasive screening test that could one day enable earlier detection of pancreatic cancer. The goal? To turn this deadly disease into a more manageable condition, and give patients real hope for the future.
As we recognize Pancreatic Cancer Awareness Month in November, this episode emphasizes the urgent need for improved diagnostic methods, more effective treatments, and continued research to change the outcome for patients everywhere.
Episode 74: Breaking Down Multiple Myeloma’s New Subtypes and Their Impact
TGen Talks
16 minutes 15 seconds
1 year ago
Episode 74: Breaking Down Multiple Myeloma’s New Subtypes and Their Impact
Scientists at TGen have released the results of a more than decade-long study into multiple myeloma. Looking at more than 1100 patients from four different countries, scientists identified new genetic subtypes of the disease, providing insights that could transform how we approach treatment (see related story above).
Listen as Jonathan Keats, Ph.D., the study's senior author discusses the findings, their impact on personalized medicine, and how TGen's advanced genomic sequencing is paving the way for more effective and individualized care. In particular, the study has identified a high-risk subgroup of patients with a distressingly short median survival, highlighting the urgent need for tailored therapies and innovative clinical trials.
TGen Talks
Episode 87 of TGen Talks features Dr. Haiyong Han, who dives into his latest work on one of the deadliest of cancers: pancreatic cancer.
He breaks down why this disease is so hard to catch early, how it can grow silently for years before symptoms appear, and why identifying true positives in general population is such a big challenge.
Dr. Han also shares promising progress toward a new non-invasive screening test that could one day enable earlier detection of pancreatic cancer. The goal? To turn this deadly disease into a more manageable condition, and give patients real hope for the future.
As we recognize Pancreatic Cancer Awareness Month in November, this episode emphasizes the urgent need for improved diagnostic methods, more effective treatments, and continued research to change the outcome for patients everywhere.
